Cancer is one of the leading causes of mortality in the United States. Clearly, new strategies for therapeutic intervention are necessary. While carcinogenesis is related to multiple genetic and epigenetic events, tumor growth is dependent upon angiogenesis. Net tumor-derived angiogenesis is due to an imbalance in the over-expression of angiogenic, as compared to angiostatic factors. This dysregulation allows for the perpetuation of tumor growth and eventual metastasis. However, the mediators that orchestrate this aberrant neovascular response in cancer have not been fully elucidated. Members of the CXC chemokine family exert disparate function in regulating angiogenesis related to the presence or absence of three amino acid residues (the 'ELR' motif) in the NH2-terminus of these cytokines. CXC chemokines have potent angiogenic (ELR+) and angiostatic (ELR-) activity, and are important factors that regulate angiogenesis. The central hypothesis of this application is that net angiogenesis during tumorigenesis of solid tumors is determined, in part, by an imbalance in the expression/function of CXC chemokines that favor the over-expression of angiogenic as compared to angiostatic chemokines. This leads to an environment that perpetuates the angiogenic phenotype of the endothelium promoting tumorigenesis and metastases. The proposed studies will focus on the following specific aims: (1) To demonstrate that vascular endothelial growth factor (VEGF)-mediated angiogenesis is related to enhanced endothelial cell survival by Bcl-2- and interleukin-8-dependent mechanism(s). (2) To establish that the CXC chemokine receptor, CXCR2, is the receptor for IL-8/ELR+ CXC chemokine mediated angiogenesis. (3) To determine the mechanisms for angiostatic interferon-inducible chemokine inhibition of VEGF, bFGF, EGF, and other ELR+ CXC chemokine-induced angiogenesis. (4) To demonstrate in vivo that IFN-inducible angiostatic chemokines inhibit tumor-derived angiogenesis, tumorigenesis, and spontaneous metastases in murine models of tumorigenesis. These experiments will use molecular, cellular, and whole animal models of angiogenesis related to tumorigenesis. The experiments in this application are designed to demonstrate that CXC chemokines mechanistically play a critical role in regulating angiogenesis during tumorigenesis. It is speculated that these investigations will provide a foundation for the development of novel therapeutic strategies to modulate this biology and attenuate tumor-derived angiogenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA087879-01
Application #
6191068
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Mohla, Suresh
Project Start
2000-07-15
Project End
2005-06-30
Budget Start
2000-07-15
Budget End
2001-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$344,250
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Choi, Young H; Burdick, Marie D; Strieter, Brett A et al. (2014) CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells. Mol Cancer Res 12:38-47
Cekic, Caglar; Sag, Duygu; Li, Yuesheng et al. (2012) Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol 188:198-205
Keeley, Ellen C; Mehrad, Borna; Strieter, Robert M (2011) Chemokines as mediators of tumor angiogenesis and neovascularization. Exp Cell Res 317:685-90
Struyf, Sofie; Salogni, Laura; Burdick, Marie D et al. (2011) Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. Blood 117:480-8
Keeley, Ellen C; Moorman, J Randall; Liu, Ling et al. (2011) Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease. PLoS One 6:e21174
Keeley, Ellen C; Mehrad, Borna; Strieter, Robert M (2010) Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 42:535-42
Shim, Y Michael; Paige, Mikell; Hanna, Halim et al. (2010) Role of LTB? in the pathogenesis of elastase-induced murine pulmonary emphysema. Am J Physiol Lung Cell Mol Physiol 299:L749-59
Choi, Young H; Burdick, Marie D; Strieter, Robert M (2010) Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes. Int J Biochem Cell Biol 42:662-71
Andersson, Asa; Yang, Seok-Chul; Huang, Min et al. (2009) IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer. J Immunol 182:6951-8
Reckamp, Karen L; Figlin, Robert A; Burdick, Marie D et al. (2009) CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. BMC Cancer 9:213

Showing the most recent 10 out of 77 publications